Clinical Review#: The diagnosis and management of central hypoadrenalism. by Grossman, AB

The molecular biology of pituitary tumors: a personal perspective. by Grossman, AB

Medical therapy of pituitary tumours: What is on the horizon? by Grossman, AB

The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful? by Grossman, AB

Reply to Swartz by Grossman, AB

Update on neuroendocrine tumours by Grossman, AB

Where metabolism meets oncogenesis: another false lead? by Grossman, AB

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies. by Nölting, S, Grossman, AB

Pheochromocytomas and paragangliomas: assessment of malignant potential. by Korevaar, T, Grossman, AB

Pheochromocytomas and paragangliomas: assessment of malignant potential by Korevaar, T, Grossman, AB

Adrenal incidentalomas: 'the rule of four'. by Alexandraki, K, Grossman, AB

Growth hormone-releasing peptides (GHRP) and their analogues by Korbonits, M, Grossman, AB

Medical therapy of Cushing's disease: where are we now? by Alexandraki, K, Grossman, AB

[Growth hormone-releasing peptides (GHRP) and their analogues] by Korbonits, M, Grossman, AB

Medullary thyroid cancer: molecular biology and novel molecular therapies. by Cakir, M, Grossman, AB

Akting and cycling: a tale of the pituitary. by Grossman, AB, Korbonits, M

The molecular pathogenesis of corticotroph tumors. by Dahia, P, Grossman, AB

Malignant pituitary tumours. by Kaltsas, G, Grossman, AB

Commentary: imaging of islet-cell tumours. by Grossman, AB, Reznek, R

Pituitary radiotherapy. by Molitch, M, Grossman, AB